Three fluoropyrimidine-based regimens in second-line therapy following nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer: Efficacy and tolerance in clinical practice.

Affiliation auteurs!!!! Error affiliation !!!!
TitreThree fluoropyrimidine-based regimens in second-line therapy following nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer: Efficacy and tolerance in clinical practice.
Type de publicationJournal Article
Year of Publication2018
AuteursPointet ALaure, Tougeron D, Pernot S, Pozet A, Bechade D, Trouilloud I, Lourenco N, Hautefeuille V, Locher C, Williet N, Desrame J, Bidault AThirot, Pezet D, Taieb J
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume36
Date PublishedFEB 1
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2018.36.4_suppl.370